PFA
BIIB icon

Pure Financial Advisors’s Biogen BIIB Stock Holding History

Pure Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$311K Sell
1,438
-286
-17% -$54.7K ﹤0.01% 498
2026
Q1 		$316K Buy
1,724
+551
+47% +$102K ﹤0.01% 446
2025
Q4 		$206K Buy
+1,173
New +$192K ﹤0.01% 512

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pure Financial Advisors's BIIB Position: Q2 2026 in Review

Pure Financial Advisors reduced its Biogen (BIIB) stake by 17% in Q2 2026, selling an estimated $54.7K and leaving 1,438 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #498.

Pure Financial Advisors first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. The position peaked at $316K in Q1 2026. 1,038 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Pure Financial Advisors held 1,438 shares of Biogen worth $311K as of Q2 2026.
  • Pure Financial Advisors sold 286 Biogen shares in Q2 2026, an estimated $54.7K.
  • Biogen made up ﹤0.01% of Pure Financial Advisors's portfolio in Q2 2026, its #498 holding.
  • Pure Financial Advisors first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • Pure Financial Advisors's Biogen position peaked at $316K in Q1 2026.
  • 1,038 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Pure Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.